Cytomegalovirus infection post‐pancreas–kidney transplantation – results of antiviral prophylaxis in high‐risk patients

Abstract

Forty-four per cent (25/57) of the D+/R- recipients developed CMV infection/disease despite CMV prophylaxis. Current CMV prophylaxis failed to prevent CMV infection/disease in this group of patients.